France Drug Testing Market Size & Outlook, 2025-2030
The drug testing market in France is expected to reach a projected revenue of US$ 804.4 million by 2030. A compound annual growth rate of 5.3% is expected of France drug testing market from 2025 to 2030.
Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories
Other key industry trends
In terms of revenue, France accounted for 4.3% of the global drug testing market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany drug testing market is projected to lead the regional market in terms of revenue in 2030.
UK is the fastest growing regional market in Europe and is projected to reach USD 1,211.1 million by 2030.
The growth of France's drug testing market can prominently be attributed to rising consumption of illicit drugs, misuse of prescriptions, and stringent government regulations. Furthermore, growing illegal handling and supply of illicit drugs is projected to have a positive impact on the market.
In January 2022, the Spanish Civil Guard arrested 11 culprits for illegal transportation of cannabis. Furthermore, in October 2022, two people were arrested for carrying liquid MMDA of around 300 kg. In addition, increase in government initiatives to boost drug abuse testing is anticipated to propel the demand for testing solutions in France.
For instance, in 2017, the French government increased the use of roadside saliva testing to reduce cases of driving under the influence. Furthermore, increased rate of workplace drug abuse in the country is expected to boost the demand for effective drug testing products.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Testing Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 36.26% in 2024.
Horizon Databook has segmented the France drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of France's drug testing market can prominently be attributed to rising consumption of illicit drugs, misuse of prescriptions, and stringent government regulations. Furthermore, growing illegal handling and supply of illicit drugs is projected to have a positive impact on the market.
In January 2022, the Spanish Civil Guard arrested 11 culprits for illegal transportation of cannabis. Furthermore, in October 2022, two people were arrested for carrying liquid MMDA of around 300 kg. In addition, increase in government initiatives to boost drug abuse testing is anticipated to propel the demand for testing solutions in France.
For instance, in 2017, the French government increased the use of roadside saliva testing to reduce cases of driving under the influence. Furthermore, increased rate of workplace drug abuse in the country is expected to boost the demand for effective drug testing products.
France Drug Testing Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables
Instruments
Rapid Testing Devices
Services
France Drug Testing Market Sample Type Outlook (Revenue, USD Million , 2018-2030)
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples
France Drug Testing Market Drug Type Outlook (Revenue, USD Million , 2018-2030)
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others
France Drug Testing Market End Use Outlook (Revenue, USD Million , 2018-2030)
Drug Testing Laboratories
Workplaces
Hospitals
Other
Reasons to subscribe to Drug Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Testing Market Outlook databook
Our clientele includes a mix of Drug Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France Drug Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into France Drug Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.